Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02250326 |
|---|---|
| Brief Title: | Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer (abound2L+) |
| First Submitted : | September 24, 2014 |
| First Submitted that Met QC Criteria : | September 24, 2014 |
| First Posted : | September 26, 2014 (Estimate) |
| Results First Submitted : | July 13, 2018 |
| Results First Submitted that Met QC Criteria : | August 9, 2018 |
| Results First Posted : | August 10, 2018 |
| Last Update Submitted that Met QC Criteria : | December 19, 2019 |
| Last Update Posted : | December 30, 2019 |